German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study evaluates the efficacy and tolerability of a risk- and subtype-adapted chemotherapy
over one year, followed by randomized either intensified or conventional maintenance therapy.
It includes a distinct protocol for the subgroup 'mature B-ALL',